Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice

The principal reason for failure of targeted cancer therapies is the emergence of resistant clones that regenerate the tumor. Therapeutic efficacy therefore depends on not only how effectively a drug inhibits its target, but also the innate or adaptive functional redundancy of that target and its at...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Soucek, Laura, Whitfield, Jonathan R., Sodir, Nicole M., Massó-Vallés, Daniel, Serrano, Erika, Karnezis, Anthony N., Swigart, Lamorna Brown, Evan, Gerard I.
Format: Artigo
Idioma:Inglês
Publicat: Cold Spring Harbor Laboratory Press 2013
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3605464/
https://ncbi.nlm.nih.gov/pubmed/23475959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/gad.205542.112
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars